Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,002 public trials 1,214 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

NCT00107237

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

Duke Univaersity Medical Center Durham, North Carolina, United States

MD Anderson Cancer Center/University of Texas Houston, Texas, United States

View Trial Details

Completed

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

NCT00004016

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +11 more
Locations: University of Rochester Cancer Center Rochester, New York, United States

View Trial Details

Completed

Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

NCT00027716

Conditions: Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

University of Chicago Cancer Research Center New York, United States

View Trial Details

Completed

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

NCT00027742

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

NCT00101270

Conditions: Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

NCT00077454

Conditions: Astrocytoma, Familial ependymoma, Glioma, +28 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

NCT00060125

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission

NCT00002458

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

NCT00026143

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

NCT00091182

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +99 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details